Home/Vesper Bio/Anders Nykjær

AN

Anders Nykjær

Founder

Therapeutic Areas

Neurology Ophthalmology

Vesper Bio Pipeline

Drug	Indication	Phase
VES001	Frontotemporal Degeneration (FTD-GRN)	Phase 2
Sortilin Inhibitor Program	Parkinson's Disease	Preclinical

Leadership Team at Vesper Bio

Business Development Consultant

Medicinal Chemistry Consultant

John King-Underwood

Medicinal Chemistry Consultant

View full Vesper Bio profile